VP, DM1 Commercial Asset Lead (Biotech)

Location: Onsite in Waltham, Massachusetts, United States

Salary: $272,000–$340,000 USD base pay annually

Company

hirify.global is a clinical-stage biotechnology company developing oligonucleotide therapeutics for genetically driven neuromuscular diseases.

What you will do

• Define the global commercialization strategy and execution plan for the DM1 asset.
• Lead launch planning and readiness across key markets, starting with the United States.
• Shape competitive positioning, product differentiation, value proposition, label strategy, and access planning.
• Lead the DM1 Commercial Sub-Team and drive cross-functional decisions across medical, regulatory, supply, marketing, digital, and data functions.
• Partner with affiliate teams and external stakeholders to support reimbursement and market access readiness.
• Engage with key opinion leaders, patient advocacy groups, care teams, payers, regulators, and senior leadership.

Requirements

• Bachelor’s degree in a relevant scientific, medical, or business discipline; an advanced degree is strongly preferred.
• Minimum of 20 years of experience in the biopharmaceutical industry.
• At least 15 years of commercialization and cross-functional leadership experience.
• Extensive global product launch experience, including at least three launches.
• Experience steering assets from late-stage development through approval and launch, including global and U.S. market access and reimbursement readiness.
• Onsite work in Waltham, Massachusetts, United States is required.

Nice to have

• Rare disease experience.
• Neuromuscular disease experience.

Culture & Benefits

• Patient-centric work focused on functional improvement for people living with genetically driven diseases.
• Collaboration across clinical, medical, regulatory, supply, and commercial functions.
• Opportunity to contribute to a broad neuromuscular disease pipeline and global launch programs.